New shot targets root cause of Tough-to-Treat asthma

NCT ID NCT06748053

Ongoing Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study is testing a new long-lasting injection called GSK5784283 for adults whose asthma remains poorly controlled despite using standard daily inhaler medications. The drug works by blocking a specific protein in the body (TSLP) thought to drive asthma inflammation. Researchers aim to find the best dose by measuring lung function, asthma control, and safety over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Miami, Florida, 33144, United States
GSK Investigational Site

Miami, Florida, 33166, United States
GSK Investigational Site

Miami, Florida, 33172, United States
GSK Investigational Site

Miami, Florida, 33173, United States
GSK Investigational Site

Plantation, Florida, 33324, United States
GSK Investigational Site

Sanford, Florida, 32771, United States
GSK Investigational Site

Tampa, Florida, 33607, United States
GSK Investigational Site

Skokie, Illinois, 60077, United States
GSK Investigational Site

Iowa City, Iowa, 52242, United States
GSK Investigational Site

Shreveport, Louisiana, 71105, United States
GSK Investigational Site

Lathrup Village, Michigan, 48076, United States
GSK Investigational Site

Warren, Michigan, 48088, United States
GSK Investigational Site

St Louis, Missouri, 63119, United States
GSK Investigational Site

Omaha, Nebraska, 68198, United States
GSK Investigational Site

The Bronx, New York, 10461, United States
GSK Investigational Site

Pineville, North Carolina, 28210, United States
GSK Investigational Site

Cincinnati, Ohio, 45236, United States
GSK Investigational Site

DuBois, Pennsylvania, 15801, United States
GSK Investigational Site

Philadelphia, Pennsylvania, 19140, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15241, United States
GSK Investigational Site

Wyomissing, Pennsylvania, 19610, United States
GSK Investigational Site

Warwick, Rhode Island, 02886, United States
GSK Investigational Site

Greenville, South Carolina, 29607, United States
GSK Investigational Site

Spartanburg, South Carolina, 29303, United States
GSK Investigational Site

Knoxville, Tennessee, 37909, United States
GSK Investigational Site

Boerne, Texas, 78006, United States
GSK Investigational Site

Cypress, Texas, 77429, United States
GSK Investigational Site

Dallas, Texas, 75225, United States
GSK Investigational Site

Houston, Texas, 77030, United States
GSK Investigational Site

Houston, Texas, 77058, United States
GSK Investigational Site

Kerrville, Texas, 78028, United States
GSK Investigational Site

McKinney, Texas, 75069, United States
GSK Investigational Site

San Antonio, Texas, 78212, United States
GSK Investigational Site

San Antonio, Texas, 78229, United States
GSK Investigational Site

Sherman, Texas, 75092, United States
GSK Investigational Site

American Fork, Utah, 84003, United States
GSK Investigational Site

Pleasant View, Utah, 84404, United States
GSK Investigational Site

Salt Lake City, Utah, 84117, United States
GSK Investigational Site

South Ogden, Utah, 84405, United States
GSK Investigational Site

Bellingham, Washington, 98225, United States
GSK Investigational Site

Blagoevgrad, 2700, Bulgaria
GSK Investigational Site

Gorna Oryahovitsa, 5100, Bulgaria
GSK Investigational Site

Lovech, 5500, Bulgaria
GSK Investigational Site

Pazardzhik, 4400, Bulgaria
GSK Investigational Site

Plovdiv, 4002, Bulgaria
GSK Investigational Site

Rousse, 7000, Bulgaria
GSK Investigational Site

Rousse, 7002, Bulgaria
GSK Investigational Site

Sofia, 1000, Bulgaria
GSK Investigational Site

Sofia, 1142, Bulgaria
GSK Investigational Site

Sofia, 1233, Bulgaria
GSK Investigational Site

Sofia, 1431, Bulgaria
GSK Investigational Site

Sofia, 1680, Bulgaria
GSK Investigational Site

Stara Zagora, Bulgaria
GSK Investigational Site

Varna, 9000, Bulgaria
GSK Investigational Site

Vratsa, 3000, Bulgaria
GSK Investigational Site

Kelowna, British Columbia, V1Y 4N7, Canada
GSK Investigational Site

Ajax, Ontario, L1S 2J5, Canada
GSK Investigational Site

London, Ontario, N6A 4V2, Canada
GSK Investigational Site

Toronto, Ontario, M5G 1E2, Canada
GSK Investigational Site

Windsor, Ontario, N8X 1T3, Canada
GSK Investigational Site

Trois-Rivières, Quebec, G8T 7A1, Canada
GSK Investigational Site

Brandýs nad Labem, 25001, Czechia
GSK Investigational Site

Mladá Boleslav, 293 01, Czechia
GSK Investigational Site

Teplice, 415 01, Czechia
GSK Investigational Site

Bendorf, 56170, Germany
GSK Investigational Site

Berlin, 10961, Germany
GSK Investigational Site

Berlin, 12203, Germany
GSK Investigational Site

Darmstadt, 64283, Germany
GSK Investigational Site

Frankfurt, 60596, Germany
GSK Investigational Site

Fürstenwalde, 15517, Germany
GSK Investigational Site

Leipzig, 04347, Germany
GSK Investigational Site

Magdeburg, 39120, Germany
GSK Investigational Site

Mainz, 55128, Germany
GSK Investigational Site

München, 81241, Germany
GSK Investigational Site

Neu-Isenburg, 63263, Germany
GSK Investigational Site

Schleswig, 24837, Germany
GSK Investigational Site

Chiba, 275-8580, Japan
GSK Investigational Site

Fukui, 910-8526, Japan
GSK Investigational Site

Fukuoka, 806-8501, Japan
GSK Investigational Site

Fukuoka, 811-1394, Japan
GSK Investigational Site

Fukushima, 960-1295, Japan
GSK Investigational Site

Gifu, 509-6134, Japan
GSK Investigational Site

Hiroshima, 734-8530, Japan
GSK Investigational Site

Hokkaido, 064-0804, Japan
GSK Investigational Site

Hyōgo, 653-0013, Japan
GSK Investigational Site

Kagawa, 762-8550, Japan
GSK Investigational Site

Kanagawa, 236-0051, Japan
GSK Investigational Site

Mie, 515-8544, Japan
GSK Investigational Site

Nagasaki, 852-8501, Japan
GSK Investigational Site

Okayama, 702-8055, Japan
GSK Investigational Site

Osaka, 596-8501, Japan
GSK Investigational Site

Shizuoka, 420-8527, Japan
GSK Investigational Site

Tokyo, 141-8625, Japan
GSK Investigational Site

Tokyo, 162-8655, Japan
GSK Investigational Site

Tokyo, 204-8585, Japan
GSK Investigational Site

Yokohama, 232-0024, Japan
GSK Investigational Site

Bacau, 600252, Romania
GSK Investigational Site

Brasov, 500283, Romania
GSK Investigational Site

Brasov, 500366, Romania
GSK Investigational Site

Bucharest, 050159, Romania
GSK Investigational Site

Cluj-Napoca, 400139, Romania
GSK Investigational Site

Craiova Dolj, 200515, Romania
GSK Investigational Site

Timișoara, 300310, Romania
GSK Investigational Site

Alcorcon Madrid, 28922, Spain
GSK Investigational Site

Barcelona, 08035, Spain
GSK Investigational Site

Barcelona, Spain
GSK Investigational Site

Benalmádena, 29631, Spain
GSK Investigational Site

Jerez de la Frontera, 11407, Spain
GSK Investigational Site

Madrid, 28003, Spain
GSK Investigational Site

Madrid, 28007, Spain
GSK Investigational Site

Madrid, 28031, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Madrid, 28223, Spain
GSK Investigational Site

Málaga, 29010, Spain
GSK Investigational Site

Santander, 39008, Spain
GSK Investigational Site

Seville, 41012, Spain
GSK Investigational Site

Valencia, 46015, Spain
GSK Investigational Site

Valencia, 46017, Spain
GSK Investigational Site

Zaragoza, 50009, Spain
GSK Investigational Site

Bradford, BD9 6RJ, United Kingdom
GSK Investigational Site

London, EC1M 6BQ, United Kingdom
GSK Investigational Site

London, SE1 9RT, United Kingdom
GSK Investigational Site

Newcastle upon Tyne, NE1 4LP, United Kingdom
GSK Investigational Site

Little Rock, Arkansas, 72205, United States
GSK Investigational Site

Long Beach, California, 90815, United States
GSK Investigational Site

Los Angeles, California, 90025, United States
GSK Investigational Site

Redding, California, 96001, United States
GSK Investigational Site

Riverside, California, 92506, United States
GSK Investigational Site

Sacramento, California, 95817, United States
GSK Investigational Site

San Jose, California, 95117, United States
GSK Investigational Site

Colorado Springs, Colorado, 80923, United States
GSK Investigational Site

Lakewood, Colorado, 80228-1813, United States
GSK Investigational Site

Wheat Ridge, Colorado, 80033, United States
GSK Investigational Site

New Haven, Connecticut, 06511, United States
GSK Investigational Site

Aventura, Florida, 33180, United States
GSK Investigational Site

Hialeah, Florida, 33012, United States
GSK Investigational Site

Lake Worth, Florida, 33460, United States
GSK Investigational Site

Leesburg, Florida, 34748, United States

Conditions

Explore the condition pages connected to this study.

ASTHMA